SAREPTA THERAPEUTICS, INC. Available-for-sale Securities
SAREPTA THERAPEUTICS, INC. (SRPT) had Available-for-sale Securities of $792.86 million as of 2018-09-30, per its 10-Q filed 2018-10-31.
Discontinued › Notes › Investments
us-gaap:AvailableForSaleSecurities · last filed 2018-10-31
- 2018-09-30: Available-for-sale Securities $792.86M.
- 2018-06-30: Available-for-sale Securities $949.14M.
- 2018-03-31: Available-for-sale Securities $1.05B.
- 2017-12-31: Available-for-sale Securities $1.09B.
| Period end | Available-for-sale Securities |
|---|---|
| 2018-09-30 | $792.86M 10-Q · filed 2018-10-31 |
| 2018-06-30 | $949.14M 10-Q · filed 2018-08-08 |
| 2018-03-31 | $1.05B 10-Q · filed 2018-05-03 |
| 2017-12-31 | $1.09B 10-Q · filed 2018-10-31 |
| 2017-09-30 | $0.00 10-Q · filed 2017-11-01 |
| 2017-06-30 | $300.95M 10-Q · filed 2017-08-03 |
| 2017-03-31 | $390.31M 10-Q · filed 2017-05-04 |
| 2016-12-31 | $317.85M 10-K · filed 2018-03-01 |
| 2016-09-30 | $0.00 10-Q · filed 2016-11-07 |
| 2016-06-30 | $123.22M 10-Q · filed 2016-08-09 |
| 2016-03-31 | $129.16M 10-Q · filed 2016-05-05 |
| 2015-12-31 | $192.49M 10-K · filed 2017-02-28 |
| 2015-09-30 | $99.91M 10-Q · filed 2015-11-05 |
| 2015-06-30 | $156.89M 10-Q · filed 2015-08-06 |
| 2015-03-31 | $166.22M 10-Q · filed 2015-05-07 |
| 2014-12-31 | $210.34M 10-K · filed 2016-02-25 |
| 2014-09-30 | $236.02M 10-Q · filed 2014-11-06 |
| 2013-12-31 | $256.96M 10-K · filed 2015-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |